Bettina Ryll, Kjetil Taskén & Anni Lepland: PRIME-ROSE & EU Joint Action
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with three leaders advancing precision cancer medicine implementation in Europe:
Bettina Ryll: Stockholm School of Economics, Institute for Research; Founder, Melanoma Patient Network Europe.
Kjetil Taskén: Head of the Institute for Cancer Research, Oslo University Hospital; Professor, University of Oslo; Coordinator, PRIME-ROSE.
Anni Lepland: Head of Personalized Medicine in Oncology, Estonian Cancer Network.
They explore how Europe’s new Joint Action can accelerate equitable precision oncology, what…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.